2017
DOI: 10.1111/sdi.12656
|View full text |Cite
|
Sign up to set email alerts
|

Improving wellbeing in patients undergoing dialysis: Can meditation help?

Abstract: Coping with the stress and anxiety caused by end stage kidney disease (ESKD) symptoms, treatment, restrictions, and social, financial and family stressors, consumes many afflicted with kidney disease. Meditation has been shown to decrease anxiety and stress, and improve wellbeing and quality of life of people with chronic disease. However, the clinical uptake of meditation is low in the ESKD dialysis population. This review describes what meditation and mindful meditation are and how they have been used for pe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
16
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 30 publications
1
16
0
1
Order By: Relevance
“…Previous studies with mindfulness components in the ESKD and dialysis population have evaluated mindfulness-based stress reduction (MBSR), meditation techniques such as Benson's technique and cognitive behavioral therapy (CBT), and positive psychology with components of mindfulness. Varying results, albeit with a general trend toward improvement in measures including depression, anxiety, stress, sleep, and quality of life, have been reported [21][22][23][24][25][26]. However, existing studies remain limited in number and suffer from a lack of active control comparators.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies with mindfulness components in the ESKD and dialysis population have evaluated mindfulness-based stress reduction (MBSR), meditation techniques such as Benson's technique and cognitive behavioral therapy (CBT), and positive psychology with components of mindfulness. Varying results, albeit with a general trend toward improvement in measures including depression, anxiety, stress, sleep, and quality of life, have been reported [21][22][23][24][25][26]. However, existing studies remain limited in number and suffer from a lack of active control comparators.…”
Section: Introductionmentioning
confidence: 99%
“…13 For some dialysis patients, nonpharmacological treatments are preferable to antidepressant SSRIs given their already high pill burden and treatment preferences. 14 Nonpharmacological treatments include therapies such as CBT, 15 meditation, 16 exercise, 17 acupressure, 18 quality of life therapy (QOLT), 19 painting and drawing therapy, 20,21 mindfulness-based art therapy, 22 music therapy, [23][24][25] web-based interventions, 26 and laughter therapy. 27 From the nonpharmacological interventions, CBT is the only nonpharmacological intervention tested in suitably powered randomized trials.…”
Section: Introductionmentioning
confidence: 99%
“…Research shows positive results from Mindfulness-Based Interventions (MBIs) in reducing symptoms of different chronic diseases and mental and physical disorders such as depression, anxiety (Chiodelli et al 2020;Murphy 2016), hypertension (Solano López 2018), irritable bowel syndrome, cancer, chronic pain, cardiovascular diseases (Carlson 2012), insomnia (Garland et al 2014;Ong et al 2014), addictive behaviors (Bowen et al 2014), and kidney disease (Bennett et al 2018;Thomas et al 2017), and in improving medication adherence (Salmoirago-Blotcher and Carey 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Mindfulness-Based Cognitive Therapy (MBCT) (Segal et al 2002) are normally offered in groups for 8 weeks, with sessions ranging from 2 to 2.5 h. The majority of the formal practices, performed in a sitting posture or lying down, last for 10 to 30 min each and the formal practice of Mindfulness for 45 min daily is encouraged. Many people are unable to adhere to these models, due to personal characteristics or specific health problems, such as people with chronic pain (Cusens et al 2010), cancer (Glynn et al 2020), cognitive problems (Russell and Arcuri 2015), addictive disorders (Bowen et al 2014), and those with CKD that perform HD (Bennett et al 2018;Gross et al 2017;Thomas et al 2017).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation